The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $166.35

Today's change-0.07 -0.04%
Updated July 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $166.35

Today's change-0.07 -0.04%
Updated July 29 4:00 PM EDT. Delayed by at least 15 minutes.

Illumina Inc down slightly

Illumina Inc closed down just (U.S.)$0.07 Friday to (U.S.)$166.35. Over the last five days, shares have gained 10.34%, but are down 13.33% for the last year to date. Shares have underperformed the S&P 500 by 26.49% during the last year.

Key company metrics

  • Open(U.S.) $165.97
  • Previous close(U.S.) $166.42
  • High(U.S.) $166.63
  • Low(U.S.) $163.11
  • Bid / Ask(U.S.) $163.40 / (U.S.) $166.66
  • YTD % change-13.33%
  • Volume1,217,434
  • Average volume (10-day)1,210,036
  • Average volume (1-month)1,338,456
  • Average volume (3-month)1,350,564
  • 52-week range(U.S.) $127.10 to (U.S.) $220.86
  • Beta0.86
  • Trailing P/E57.18×
  • P/E 1 year forward47.52×
  • Forward PEG2.98×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.91
Updated July 29 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.24%

Based on its net profit margin of 18.24%, Illumina Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.21%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 03, 201604/03/2016Jan 03, 201601/03/2016Sep 27, 201509/27/2015Jun 28, 201506/28/2015
Revenue572592550539
Total other revenue--------
Total revenue572592550539
Gross profit397410388376
Total cost of revenue175181163163
Total operating expense450448409387
Selling / general / administrative149147137124
Research & development1241149996
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)25114
Other operating expenses, total--------
Operating income121144141152
Interest income (expense), net non-operating-9-7-13-11
Gain (loss) on sale of assets--------
Other--------
Income before tax116135129141
Income after tax87103116102
Income tax, total28321339
Net income90104118102
Total adjustments to net income--------
Net income before extra. items90104118102
Minority interest223--
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items90104118102
Inc. avail. to common incl. extra. items90104118102
Diluted net income90104118102
Dilution adjustment--------
Diluted weighted average shares148149150149
Diluted EPS excluding extraordinary itemsvalue per share0.600.700.790.69
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.620.730.850.70